|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0013455,
umls-concept:C0027442,
umls-concept:C0239127,
umls-concept:C0282386,
umls-concept:C0338237,
umls-concept:C0441655,
umls-concept:C0450254,
umls-concept:C0450442,
umls-concept:C0521367,
umls-concept:C0747085,
umls-concept:C1301820,
umls-concept:C1533691,
umls-concept:C1704353
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-6-27
|
|
pubmed:abstractText |
This study analyzes the in vitro activities of levofloxacin and other commonly used antimicrobials against middle ear fluid, nasopharyngeal, and oropharyngeal pathogens obtained from children with otitis media at risk of having a resistant pathogen. Levofloxacin proved to be very active against these pathogens and had intermediate activity against Streptococcus pyogenes.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-10984323,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-11959559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-12356793,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-14614364,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-14614365,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-14688566,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-15121972,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-15131460,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-15328089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-7177897,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15980399-9726340
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3056-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15980399-Anti-Bacterial Agents,
pubmed-meshheading:15980399-Child, Preschool,
pubmed-meshheading:15980399-Costa Rica,
pubmed-meshheading:15980399-Haemophilus influenzae,
pubmed-meshheading:15980399-Humans,
pubmed-meshheading:15980399-Infant,
pubmed-meshheading:15980399-Microbial Sensitivity Tests,
pubmed-meshheading:15980399-Moraxella (Branhamella) catarrhalis,
pubmed-meshheading:15980399-Nasopharynx,
pubmed-meshheading:15980399-Ofloxacin,
pubmed-meshheading:15980399-Oropharynx,
pubmed-meshheading:15980399-Otitis Media with Effusion,
pubmed-meshheading:15980399-Recurrence,
pubmed-meshheading:15980399-Streptococcus pneumoniae,
pubmed-meshheading:15980399-Streptococcus pyogenes,
pubmed-meshheading:15980399-Treatment Failure
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
In vitro activities of levofloxacin and comparable agents against middle ear fluid, nasopharyngeal, and oropharyngeal pathogens obtained from Costa Rican children with recurrent otitis media or failing other antibiotic therapy.
|
|
pubmed:affiliation |
Instituto de Atención Pediátrica, P.O. Box 607-1150, San José, Costa Rica.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
